According to Array Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.4118. At the end of 2022 the company had a P/E ratio of -69.0.
Year | P/E ratio | Change |
---|---|---|
2022 | -69.0 | 120% |
2021 | -31.4 | -133.61% |
2020 | 93.4 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Novartis NVS | 26.5 | 13.13% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | 134 | 470.27% | ๐บ๐ธ USA |
Amgen AMGN | 19.0 | -18.68% | ๐บ๐ธ USA |
AstraZeneca AZN | 37.8 | 61.45% | ๐ฌ๐ง UK |
Onconova Therapeutics ONTX | -0.9953 | -104.25% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.